Does ABALOPARATIDE Cause Injection site extravasation? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Injection site extravasation have been filed in association with ABALOPARATIDE (Tymlos). This represents 0.1% of all adverse event reports for ABALOPARATIDE.
13
Reports of Injection site extravasation with ABALOPARATIDE
0.1%
of all ABALOPARATIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site extravasation From ABALOPARATIDE?
Of the 13 reports.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABALOPARATIDE. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ABALOPARATIDE Cause?
Headache (4,048)
Nausea (3,134)
Dizziness (3,005)
Fatigue (2,637)
Heart rate increased (2,092)
Palpitations (1,730)
Arthralgia (1,711)
Bone pain (1,360)
Back pain (1,229)
Pain (1,191)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which ABALOPARATIDE Alternatives Have Lower Injection site extravasation Risk?
ABALOPARATIDE vs ABATACEPT
ABALOPARATIDE vs ABATACEPT SUBQ /ML
ABALOPARATIDE vs ABCIXIMAB
ABALOPARATIDE vs ABEMACICLIB
ABALOPARATIDE vs ABILIFY